A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
Conditions
Slow-Flow Vascular Malformation · Fast-Flow Vascular Malformation · Vascular Malformations · Venous Malformation · Lymphatic Malformation, Low Flow · Lymphatic Malformation · Lymphangioma · Arteriovenous Malformations · Venous Malformation, Low Flow · Cystic Hygroma · Vascular Anomaly · Vascular Anomalies · PI3K Gene Mutation · MAP2K1 Gene Mutation · PIK3CA-related Overgrowth Spectrum · Arteriovenous Malformation (AVM) · KRAS G12C · KRAS G12D
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peter MacCallum Cancer Centre, Parkville, Victoria, Australia
Contact: Principal Investigator (Stephen Luen, MBChB, FRACP)The Royal Children's Hospital, Parkville, Victoria, Australia
Contact: Study coordinator (Anthony Penington, MBBS, FRACS, MD(res), Grad Dip) · Tony.Penington@rch.org.au · +61403342847Contact: Study coordinator (Michelle de Silva, BSc(Hons), PhD, MGenCouns) · michelle.desilva@vcgs.org.au · +61399366109
Study leads
Tony Penington, MBBS, FRACS.
Principal Investigator
Study Principal Investigator
Stephen Luen, MBChB, FRACP.
Principal Investigator
Principal Investigator
Lydia Pathmanathan, MBBS, FRACP.
Principal Investigator
Principal Investigator